gevirtz on myopain

85
The Mind/Muscle Connection: Diagnosing and Treating Chronic Pain Disorder Richard Gevirtz, Ph.D. CSPP @ Alliant International University San Diego, CA [email protected]

Upload: wilensk

Post on 13-May-2015

1.121 views

Category:

Health & Medicine


1 download

DESCRIPTION

lecture for 24/12

TRANSCRIPT

Page 1: gevirtz on myopain

The Mind/Muscle Connection: Diagnosing and Treating Chronic Pain Disorder

Richard Gevirtz, Ph.D.CSPP @ Alliant International UniversitySan Diego, CA [email protected]

Page 2: gevirtz on myopain

Collaborators

David Hubbard, M.D. & MyopointGreg Berkoff, D.C.Sonja Banks, Ph.D.Carol Lewis, Ph.D.Walt McNulty, Ph.D.Toni Cafaro, Ph.D.Jeri Muse, Ph.D.Janeen Armm, Ph.D.Ali Oliviera, M.S., R.N.

Page 3: gevirtz on myopain

Comparative Costs of Musculoskeletal, Cardiovascular, & Cancer to the U.S. Economy

0

50

100

150

200

250

300

Cost in

Billions of

$

Musculoskeletal

Cardiovascular

Cancer

Page 4: gevirtz on myopain

Chronic Muscle Pain-Epidemiology

Second only to common cold for medical treatment

75-80 million people seeking treatment(Bonica,1992)

550 million workdays lost$147 billion dollars lost in direct and

indirect costs (Am. Assoc. Orthopedics, 1995) $245 billion 2001 dollars

70% of workers compensation claims35% of work-disabling injuries (Calif. Work

comp Bull,1991)

Page 5: gevirtz on myopain

Central vs. Peripheral Pain:A key differential diagnostic distinction

It is necessary to form a hypothesis on the source or sources of pain Central

FM- Central allodynia or sensitizationCRPS- pain in a limbPhantom limb pain

PeripheralMyofascial PainIBSNeuropathic Pain

Combination

Page 6: gevirtz on myopain

Epidemiology-continued

45 million ER visits per year (Swiontkowski & Chapman, 1995)

70 million physician visits/year (Hollbrook, 1991)

425 million visits to chiropractors and “alternative” providers , $4.0 billion(Eisenberg, 1993)

20% of general population(Magni,1993)80% lifetime incidence (Bonica, 1990)

Page 7: gevirtz on myopain

Narrative:

Starting Anomalies Disconnect between Pain and sEMG Lack of viable biomedical models Mind/muscle epidemiology and popular anecdotes

Hubbard Connection (Neuro-Epistimologist)Discovery of the Italian literature on

sympathetic enervation of spindlenEMG studiesClinical successes

Page 8: gevirtz on myopain

The Effect of a Short Educational Trigger Point Management Video on Pain Outcomes

Oliveira, Gevirtz, & Hubbard (2005)In press, Spine

126 Whiplash pts randomly assigned to video or normal ER tx

Groups well matchedFollowed at 1,3 & 6 monthsVideo group(as compared to controls)

showed good mastery of a content test on TPs (F(1,124)=262.2, Eta2=.9)

All ANOVAs and Chi2 sig., p<.001

Page 9: gevirtz on myopain

04/12/23 GevirtzGevirtz 9

Page 10: gevirtz on myopain

Short Form Musculoskeletal Function Assessment

0

5

10

15

20

25

smfa

Month1

std

Month3

std

Month6

std

No Video

Video

Page 11: gevirtz on myopain

Verbal Rating Scale

0

1

2

3

4

5

Verbal Rating Scale

Month 1 Month 3 Month 6

No Video

Video

Page 12: gevirtz on myopain

Chiropractic Visits

0

5

10

15

20

25

30

35

%

Month 1 Month 3 Month 6

No Video

Video

Page 13: gevirtz on myopain

Physical Therapy Visits

0

10

20

30

40

50

60

%

Month 1 Month 3 Month 6

No Video

Video

Page 14: gevirtz on myopain

MRIs

0

2

4

6

8

10

12

14

16

%

Month 1 Month 3 Month 6

No Video

Video

Page 15: gevirtz on myopain

ER Visits

0

5

10

15

20

%

Month 1 Month 3 Month 6

No Video

Video

Page 16: gevirtz on myopain

Urgent Care Visits

0

5

10

15

20

%

Month 1 Month 3 Month 6

No Video

Video

Page 17: gevirtz on myopain

Taking Narcotics

0

5

10

15

20

25

30

35

40

%

Month 1 Month 3 Month 6

No Video

Video

Page 18: gevirtz on myopain

Taking Muscle Relaxant

0

5

10

15

20

25

30

35

40

%

Month 1 Month 3 Month 6

No Video

Video

Page 19: gevirtz on myopain

Wearing Neck Brace

0

5

10

15

20

25

%

Month 1 Month 3 Month 6

No Video

Video

Page 20: gevirtz on myopain

Surgical Consultation

0

5

10

15

20

25

%

Month 1 Month 3 Month 6

No Video

Video

Page 21: gevirtz on myopain

Cut Back Activities

0

5

10

15

20

25

30

%

Month 1 Month 3 Month 6

No Video

Video

Page 22: gevirtz on myopain

Bed Rest

0

5

10

15

20

25

30

35

%

Month 1 Month 3 Month 6

No Video

Video

Page 23: gevirtz on myopain

Number Missed Workdays Due to Injury

0

0.2

0.4

0.6

0.8

1

1.2

%

Month 1 Month 3 Month 6

No Video

Video

Page 24: gevirtz on myopain

Primary Care Doctor Office Visits

0

10

20

30

40

50

60

70

%

Month 1 Month 3 Month 6

No Video

Video

Page 25: gevirtz on myopain

Relationship between attribution of pain etiology and pain improvement

0

5

10

15

20

25

SMFA Std

Pain

scores

Month

1

Month

3

Month

6

Attribute pain tomuscle tension

Does notattribute pain tomuscle tension

Page 26: gevirtz on myopain

04/12/23 GevirtzGevirtz 26

Why was a 12 minute video so effective in preventing chronic neck/head pain?

Answer is the core of this talk

Page 27: gevirtz on myopain

Where Does the Pain Come From?

Key question-seldom asked Is there a strong central component?

Is the pain a neurological construction absent peripheral mechanisms?

Evidence of central factors Seratonergic systems Dopaminergic systems Antidepressant medication Imaging studies Small % of the variance

Muscle Fatigue No evidence for byproducts which would indicate fatigue

Peripheral Mechanisms- Trigger Points

Page 28: gevirtz on myopain

Typical Diagnosis

Cervical Strain Lumbar StrainRepetitive Strain InjuryTension HeadacheTMJ or TMDMyofascial Pain Syndrome

Page 29: gevirtz on myopain

Wait a minute here, Mr. Crumbley, maybe its not kidney stones after all!

Page 30: gevirtz on myopain

Typical Misdiagnoses

Ruptured or bulged discPinched nerveCarpal tunnel syndromeTennis elbowBursitisThoracic Outlet SyndromeDepression (or other Psychiatric diagnosis)Fibromyalgia

Page 31: gevirtz on myopain

Etiological Theories

Fatigue/Posture modelsInflamation modelsMicro-lesionSubtle metabolic abmormalityTrigger Points

Page 32: gevirtz on myopain
Page 33: gevirtz on myopain

Trigger Points (TrPs) I

Trigger point is the sine qua non of Myofascial Pain Syndrome (MPS)

Associated stiffnessLocalized point tenderness in muscleStimulation produces local and

referred painOften with a palpable taut band

Page 34: gevirtz on myopain

TrPs II

TwitchTrigger because like a gun trigger is

initiated with pressureProduces pain in another place-

(target)

Page 35: gevirtz on myopain

04/12/23 GevirtzGevirtz 35

Page 36: gevirtz on myopain

04/12/23 GevirtzGevirtz 36

Page 37: gevirtz on myopain
Page 38: gevirtz on myopain

Gerwin, R., Shannon, S., Hong, C., Hubbard, D. & Gevirtz, R. (1997) Interrater reliability in myofascial trigger point examination. Pain, 69, 65-73.

Page 39: gevirtz on myopain
Page 40: gevirtz on myopain

04/12/23 GevirtzGevirtz 40

Page 41: gevirtz on myopain
Page 42: gevirtz on myopain
Page 43: gevirtz on myopain
Page 44: gevirtz on myopain

Myofascial Trigger Points Show Spontaneous Needle EMG Activity (Hubbard & Berkoff, 1993)

05

101520253035404550

Mean nEMG amplitude in Microvolts

Normal Ss Muscle Pain Ss

Trigger Point

Adjacent Non-tender

Page 45: gevirtz on myopain

Effects of Curare on nEMG in TPs and Adjacent, (Non-tender) Sites

TP nEMG

Adjacent nEMG

Pre Injection Post

Page 46: gevirtz on myopain

The Effect of Phentolamine Injection on TP & Adjacent nEMG

Page 47: gevirtz on myopain

04/12/23 GevirtzGevirtz 47

Phentolamine effect on the spontaneous electrical activity of active loci in a myofascial trigger spot of rabbit skeletal muscle*1 .  Archives of Physical Medicine and Rehabilitation , Volume 79 , Issue 7 , Pages 790 - 794J . Chen , S . Chen , T . Kuan , K . Chung , C . Hong

Page 48: gevirtz on myopain

Clinical Efficacy of Phenoxybenzamine (Myotech)

0102030405060708090

Percent of Patients

0

0-25

26-7

5

76-1

00

Tota

llyIm

prov

ed

percent improved

Page 49: gevirtz on myopain

Italian Spindle Studies

Passatore, Deriu, Grassi, & Raotta (1996), J.Auton N.S. Grassi, Deriu, & Passatore (1993) J. Physiology Grassi, Deriu, Artusio, & Passatore (1993) Arch Ital Biol Grassi & Passatore(1990) Functional Neurology

Found strong response in spindle could be elicited by sympathetic cervical nerve stimulation, abolished by alpha-adrenergic blockade, unaffected by sympathetically induced vasomotor changes.

“These data suggest that, when the sympathetic nervous system is activated under physiological conditions, there is a marked depression of the stretch reflex which is independent of vasomotor changes and is probably due to decrease in sensitivity of muscle spindle afferents” (Grassi, Deriu, & Passatore, 1993, p.163)

Page 50: gevirtz on myopain

04/12/23 GevirtzGevirtz 50

Page 51: gevirtz on myopain

Muscle Spindle

Page 52: gevirtz on myopain
Page 53: gevirtz on myopain

Partanen, J., J. of Physiology, 1999. The

Fusimotor Theory Revisited.

“…we have observed alpha-EPS (end plate spikes) coactivation and even independent EPS activation, not connected to muscle contraction.”

Page 54: gevirtz on myopain

Spindles are sympathetically preparing for motor action

Page 55: gevirtz on myopain
Page 56: gevirtz on myopain
Page 57: gevirtz on myopain

Trigger Point vs. Adjacent nEMGs across Conditions) McNulty,W., Gevirtz,R.N., Hubbard, D., and Berkoff,G. (1994) Needle electromyographic evaluation of trigger point response to a psychological stressor. Psychophysiology,31, (3), 313-316.

16.87

4.46

15.82

4.34

15.73

4.03

28.34

4.44

15.99

4.27

0

5

10

15

20

25

30B

asel

ine

For

Cou

nt

Rec

over

y

7's

Rec

over

y

Trigger Point

Adjacent

Page 58: gevirtz on myopain

Trigger Point vs. Adjacent nEMG vs.

Frontal sEMG Lewis, C. & Gevirtz, R.N, (1994) Needle Trigger Point and

Surface EMG easurements of Psychophysiological Responses in Tension-Type Headache Patients, Biofeedback and Self-Regulation, 19, 274-275 (abstract)

15.21

6.14

7.94

16.54

6.2

11.66

14.84

6.25

9.45

20.19

6.8

10.42

16.25

6.05

8.81

12.46

5.484.45

0

5

10

15

20

25B

ase1

For

Cou

nt

Rec

over

y 7s

Rec

over

y

Bio

feed

bk

Trigger Point

Adjacent

Frontal

Page 59: gevirtz on myopain

Autogenic Relaxation Reduces Trigger Point Activity Banks, S., Jacobs, D., Gevirtz, R. & Hubbard, D. (1998) Effects of autogenic relaxation training on EMG activity in myofascial trigger points. Journal of Musculoskeletal Pain, 6, #4.

02468

101214

nEMG activity in MicrovoltsB

ase

lin

e

Re

lax

Po

st-

Re

lax

Str

esso

r

TP

Adjacent

Page 61: gevirtz on myopain

Trigger point vs. Adjacent nEMG across Conditions Gadler, R. & Gevirtz, R.(1997) Evaluation of Needle Electromyographic Response to Emotional Stimuli Applied Psychophysiology and Biofeedback, 22, 137 (abstract)

14.9

5.61

30.29

8.69

18.07

6.08

40.21

16.58

22.78

8.64

46.2

13.6615.75

6.65

05

101520253035404550

Bas

elin

e

7"s

Rec

over

y

An

ger

Rec

over

y

Fea

r

Rec

over

y

Trigger Point

Adjacent

Page 62: gevirtz on myopain

 

0102030405060708090

nEMG in Microvolts

BaseTP

GoodErgoTP

PoorErgoTP

BaseAdj

GoodErgoAdj

PoorErgoAdj

Stress

No Stress

nEMG Across Ergonomic & Stress Conditions Muse, J. & Gevirtz, R. (1999) The effects of a psychological stressor on

nEMG activity while performing a typing task in good and poor ergonomic positions. Applied Psychophysiology and Biofeedback, 24 (2), 120 (abstract).

Page 63: gevirtz on myopain

Cafaro, T.A., Gevirtz, R.N., Hubbard, D., & Harvey, M. (2001) The exploration of trigger point and heart rate variability excitation and

recovery patterns in actors performing anger inhibition and anger expression. Applied Psychophysiology and Biofeedback, 26, 236(abstract).

 

Page 64: gevirtz on myopain

Personality Traits and Tp Worsening

In 86 1st year graduate students, the Penn State Worry Questionnaire (among a number of other predictors)predicted trigger point worsening 2-3 months later over the course of increasing stress in an academic semester, r=.35, r2=.123 (Armm, Gevirtz, Hubbard, & Harpin, 1999)

Page 65: gevirtz on myopain

Mediational Model of Muscle Pain

Muscle Pain- Myofascial Pain- TP Pain

TP or Spindle SpasmPressure on Capsule

Prolonged Sympathetic Activity

Worry or FNEongoing

Overexertion

Lack of AssertivenessSituations requiring

self-assertion

Page 66: gevirtz on myopain

TreatmentTreatment

Page 67: gevirtz on myopain

Insert Myopoint Video Here

Page 68: gevirtz on myopain
Page 69: gevirtz on myopain
Page 70: gevirtz on myopain
Page 71: gevirtz on myopain

Differential Diagnosis of FM and MPS(adapted from Schneider, 1995)

Symptom Fibromyalgia Myofascial Pain Syndrome

Pain pattern Bilateral & Widespread Regional: Specific referred pain patterns

Morning fatigue Yes No

Sleep disorder Yes: strong correlationwith FM

Sometimes: secondary to pain &discomfort of MPS

Soft tissue findings Tender point Trigger point

Palpable changes None Distinct “nodularity” over TP; Palpable,taut “ropy” bands with associated features

Female/Male ratio 10-20:1 1:1

Page 72: gevirtz on myopain

Differential (continued)

Symptoms Fibromyalgia Myofascial PainSyndrome

History / presentation Chronic, widespreadpain; morning fatigue,stiffness and pain ofunknown cause

History of acute orchronic muscle strain orinjury; regionalizedpain

Treatment approach Treatment is systemic:Low dose anti-depressantsAerobic ExercisePsychotherapyChiropracticmanipulation

Treatment is specificand local:AccupressureTherapeutic stretchInjection

Page 73: gevirtz on myopain

Treatment Considerations I

Education/Attribution ShiftUse grid,video, articles,persuasion,

diagrams, etc. to achieve shift in causal attribution

Physical management Accupressure, theracane, tennis balls,

passive stretches, moist heat, spray and stretch

Injections (Phenoxybenzamine, botulinum toxin type A, dry needling

Page 74: gevirtz on myopain

Sharp Hospital Treatment Model I

1992 to presentAverage weekly census =225 patients (one

of largest in world)61% managed care, 33% workers’

compensation67% reduction in following year health

care costsDespite average of 3.8 years disability,

67% returned to work

Page 75: gevirtz on myopain

04/12/23 GevirtzGevirtz 754/22/2003 GevirtzGevirtz 72

Page 76: gevirtz on myopain

Sharp Hospital Treatment Model II

Muscle pain education/differential diagnosis

Cognitive copingPhysical coping/gentle stretchingMedication managementUse of internsDe-emphasize traditional

psychological models

Page 77: gevirtz on myopain

Treatment II: sEmg Biofeedback Techniques

Muscle awareness Biofeedback, bilateral, symmetry, traps, frontal

Frontal EMG Cultivated Low Arousal Facial Muscle Feedback

Bi-lateral Trapezius Tx For Bracing or Splinting For Symmetry For Breathing

Specific Muscle Placement

Page 78: gevirtz on myopain

04/12/23 GevirtzGevirtz 78

HF(.15-.4Hz)LF(.08-.14Hz)

VLF(.001-.07Hz)

Page 79: gevirtz on myopain

04/12/23 GevirtzGevirtz 79

Page 80: gevirtz on myopain
Page 81: gevirtz on myopain
Page 82: gevirtz on myopain

Treatment Considerations III

Breathing/relaxation Cultivated low arousal, breathing

retraining, mindfulness techniques, etc. Resonant Frequency Training

Problem solving Using awareness of muscle tension, try

to remedy causal situation(seeing the big picture)

Page 83: gevirtz on myopain

Treatment Considerations IV

Cognitive interventions Since the model hypothesizes that

persistent sympathetic activity (even if low level) stimulates activity in the TrPs, we now look for the “smoking cognitive gun”. This is likely to center around distorted self-schema such as: “I’m only a valid person if I am pleasing others”, or “If I am not perfect I am worthless”.

Page 84: gevirtz on myopain

Wrap-Up

Summary of the arguments presented today Epidemiology Pathophysiology Treatment

Implications: Mind/Body techniques should be the first line treatment for muscle pain disorders

Page 85: gevirtz on myopain